UnitedHealth (UNH) Stock Gets Two Price Target Hikes on the Same Day – Here’s Why

TLDR

• Bank of America upgraded UNH to Buy from Neutral after five consecutive sessions of losses
• BofA analyst Kevin Fischbeck raised his price target to $450 from $420
• Q1 outperformance seen as more than just weak flu season and storm effects
• Morgan Stanley also raised its price target on UNH to $453 from $395, maintaining Overweight
• Lower April/May medical utilization data is driving bullish sentiment across managed care stocks

UnitedHealth Group (UNH) stock was set to open higher Thursday after Bank of America upgraded the stock to Buy from Neutral, snapping a five-session losing streak.

UnitedHealth Group Incorporated, UNH

BofA analyst Kevin Fischbeck raised his price target to $450 from $420, pointing to what he sees as a strong setup heading into Q2 earnings.

Fischbeck argued that UNH’s Q1 beat wasn’t just a lucky break from lower flu activity and storm-related disruptions. He said incoming data makes it “more difficult to believe” the strong quarter was purely tied to those one-off factors.

The key driver behind the upgrade is medical cost trends. BofA’s own Trend Tracker data is showing lower utilization in April and May, which tends to be good news for managed care companies’ bottom lines.

BofA Turns Broadly Bullish on MCOs

The upgrade isn’t just about UNH. Fischbeck noted BofA is more bullish on managed care organizations (MCOs) across the board heading into Q2, citing the same utilization data.

UNH is typically the first managed care company to report each quarter, giving it bellwether status for the sector. If trends hold, BofA expects UNH to pull its MCO peers higher during earnings season.

The company is expected to report Q2 2026 results next month.

Morgan Stanley Raises Target Too

BofA wasn’t alone. Morgan Stanley analyst Erin Wright also raised her price target on UNH Thursday, moving it to $453 from $395 while keeping an Overweight rating.

Wright noted that managed care stocks have been “grinding higher” on the back of softer utilization trends — the same theme driving BofA’s call.

She also flagged potential AI tailwinds for MCOs, pointing to revenue and cost efficiencies that could deliver around 45% average EPS upside as AI tools scale across the sector.

That’s an eye-catching number, though Wright framed it as a longer-term opportunity rather than something baked into near-term estimates.

Two upgrades in one day from major Wall Street firms, both pointing to the same underlying data, is a clean signal that sentiment on UNH is shifting.

Morgan Stanley’s new $453 target sits above BofA’s $450, making it the higher of the two fresh estimates on the stock.

The post UnitedHealth (UNH) Stock Gets Two Price Target Hikes on the Same Day – Here’s Why appeared first on CoinCentral.